04/24/2024
7:00 AM | PMV Pharmaceuticals (Filer)
| Form DEF 14A | |
04/24/2024
7:01 AM | PMV Pharmaceuticals (Filer)
| Form DEFA14A | |
04/24/2024
7:02 AM | PMV Pharmaceuticals (Filer)
| Form ARS | |
04/09/2024
12:17 PM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
PMV Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/29/2024
3:05 PM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:05 PM | PMV Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
2:38 PM | ArrowMark Colorado Holdings LLC (Filed by)
PMV Pharmaceuticals (Subject)
| Form SC 13G | |
|
02/14/2024
8:18 AM | Avoro Capital Advisors LLC (Filed by)
PMV Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
6:52 AM | PMV Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
01/29/2024
2:26 PM | PMV Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/24/2024
8:01 AM | PMV Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/23/2024
8:07 AM | PMV Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/23/2024
8:40 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
PMV Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/22/2024
3:02 PM | Mack David Henry (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
3:04 PM | Carulli Michael (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
3:06 PM | Jalota Deepika (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:18 PM | Carulli Michael (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/24/2023
3:38 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP V LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
7:00 AM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:00 AM | PMV Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/12/2023
4:02 PM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
3:22 PM | Alland Leila (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:26 PM | Jalota Deepika (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2023
7:00 AM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2023
7:01 AM | PMV Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/07/2023
3:35 PM | BlackRock Inc. (Filed by)
PMV Pharmaceuticals (Subject)
| Form SC 13G/A | |
06/12/2023
4:39 PM | Heyman Richard A. (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
4:49 PM | LEVINE ARNOLD J (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
4:55 PM | PMV Pharmaceuticals (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
7:01 AM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
5:14 PM | Alland Leila (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
5:18 PM | Jalota Deepika (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
4:48 PM | Mack David Henry (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
8:19 AM | PMV Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
05/10/2023
7:00 AM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
7:02 AM | PMV Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2023
11:15 PM | PMV Pharmaceuticals (Filer)
| Form EFFECT | |
04/28/2023
7:01 AM | PMV Pharmaceuticals (Filer)
| Form DEF 14A | |
04/28/2023
7:01 AM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2023
7:03 AM | PMV Pharmaceuticals (Filer)
| Form DEFA14A | |
04/28/2023
7:04 AM | PMV Pharmaceuticals (Filer)
| Form ARS | |
My top 100 stocks… (Ad) We recently ran an internal audit of every trade recommendation I’ve published across all my services…
And let me tell ya, we found some incredible insights…
For starters, we found about 100 stocks I trade really, really well. Get some cool freebies right here. |
